Cargando…
The Effect of mRNA-Based COVID-19 Vaccination on Anti-Programmed Cell Death Protein 1 Blockade for Nasopharyngeal Cancer May Differ From a Virus-Inactivated Vaccine
Autores principales: | Hayashi, Takuma, Konishi, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409552/ https://www.ncbi.nlm.nih.gov/pubmed/37560346 http://dx.doi.org/10.14740/wjon1620 |
Ejemplares similares
-
Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022) -
Significant Decrease in Seasonal Influenza in the COVID-19 Era: Impact of Global Movement Restrictions?
por: Hayashi, Takuma, et al.
Publicado: (2021) -
Noneffect of SARS-CoV-2 spike glycoprotein Y217N mutation on affinity between the virus and ACE2
por: Hayashi, Takuma, et al.
Publicado: (2021) -
Spontaneous Myocarditis in Mice Predisposed to Autoimmune Disease: Including Vaccination-Induced Onset
por: Hayashi, Takuma, et al.
Publicado: (2022) -
Potentially improved response of COVID-19 vaccinated nasopharyngeal cancer patients to combination therapy with anti-PD-1 blockade and chemotherapy
por: Hua, Y.J., et al.
Publicado: (2023)